Business Segments IDEXX Laboratories, Inc.
Equities
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 569.95 USD | -1.86% |
|
-2.53% | -15.75% |
| Apr. 15 | Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target | MT |
| Apr. 14 | Leerink Partners Adjusts IDEXX Laboratories PT to $725 From $760, Maintains Outperform Rating | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Veterinary Equipment | ||||||||||
Companion Animal Group (CAG) | 2.89B | 3.06B | 3.35B | 3.57B | 3.95B | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | 1.68B | 1.81B | 2B | 2.18B | 2.45B | |||||
D&A | 94.2M | 101M | 104M | 116M | 130M | |||||
Operating Income | 824M | 801M | 1.01B | - | 1.26B | |||||
Livestock, Poultry and Dairy (LPD) | 136M | 123M | 122M | 122M | 132M | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | 81.56M | 73M | 65.44M | 62.56M | 64.21M | |||||
D&A | 3.91M | 3.8M | 3.66M | 3.8M | 4.04M | |||||
Operating Income | 28.64M | 19.81M | 9.98M | - | 3.23M | |||||
Measuring, Analyzing, and Controlling Instruments | ||||||||||
Water | 147M | 156M | 168M | 185M | 201M | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | 101M | 110M | 116M | 130M | 139M | |||||
D&A | 2.71M | 3.02M | 4.12M | 4.73M | 4.76M | |||||
Operating Income | 65.44M | 72.52M | 74.34M | - | 93.27M | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Other | 43.01M | 30.2M | 18.79M | 16.29M | 17.48M | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | 23.12M | 14.9M | 6.1M | 7.18M | - | |||||
D&A | 3.78M | 3.83M | 3.58M | 5.12M | 6.03M | |||||
Operating Income | 13.93M | 5.49M | 73K | - | -1.04M | |||||
Operating Income | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 2B | 2.18B | 2.39B | 2.53B | 2.75B | |||||
Total Assets | 436M | 487M | 532M | 554M | 575M | |||||
Other Europe, The Middle East and Africa | 168M | 162M | 176M | 196M | 230M | |||||
Total Assets | 3.82M | 3.05M | 2.91M | 3.06M | 3.86M | |||||
Germany | 147M | 138M | 150M | 174M | 207M | |||||
Total Assets | 60.45M | 55.73M | 56.12M | 52.65M | 56.78M | |||||
Canada | 140M | 143M | 150M | 153M | 167M | |||||
Total Assets | 7M | 7.41M | 7.03M | 8.16M | 9.14M | |||||
United Kingdom | 115M | 110M | 122M | 135M | 154M | |||||
Total Assets | 9.83M | 10.71M | 10.9M | 11.14M | 13.56M | |||||
France | 90.84M | 84.48M | 96.8M | 111M | 126M | |||||
Total Assets | 1.88M | 1.51M | 1.72M | 1.77M | 2.12M | |||||
Other Asia Pacific | 89.52M | 96.29M | 104M | 110M | 124M | |||||
Total Assets | 8.26M | 7.66M | 6.98M | 7.71M | 9.95M | |||||
Australia | 94.41M | 96.41M | 95.46M | 102M | 112M | |||||
Total Assets | 14.58M | 20.24M | 21.92M | 19.31M | 20.39M | |||||
Latin America & Caribbean | 66.62M | 75.04M | 83.92M | 83.69M | 90.41M | |||||
Japan | 84.28M | 77.66M | 75.57M | 73.14M | 83.36M | |||||
Total Assets | 5.84M | 5.11M | 4.89M | 9.38M | 10.57M | |||||
Spain | 48.17M | 46.98M | 52.33M | 61.86M | 70.97M | |||||
Italy | 52.06M | 48.19M | 53.79M | 58.22M | 66.86M | |||||
Switzerland | 31.98M | 30.65M | 34.83M | 37.18M | 41.7M | |||||
Total Assets | 3.54M | 13.44M | 14.13M | 14.72M | 14.88M | |||||
Netherlands | 29.66M | 26.88M | 30.51M | 34.05M | 40.5M | |||||
Total Assets | 19.4M | 11.98M | 10.6M | 9.48M | 10.5M | |||||
China | 63.17M | 49.19M | 44.17M | 35.82M | 35.96M | |||||
Total Assets | 17.04M | 25.95M | 33.24M | 22.14M | 20.53M |
- Stock Market
- Equities
- IDXX Stock
- Financials IDEXX Laboratories, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















